Sabuwar shekara, sabon sabuntawa! An sake duba rahotanninmu don girman kasuwa, hasashe, da dabarun ɗauka akan 2021 bayan tasirin COVID-19: https://www.thebusinessresearchcompany.com/global-market-reports
Girman yawan tsufa da haɓaka fahimtar kiwon lafiya tsakanin al'ummar duniya na iya haifar da masana'antar kantin magani da kantin magani kamar yadda rahoton masana'antar kantin magani ya nuna. Yawan geriatric ya fi sauƙi don samun yawancin cututtuka waɗanda ke ƙara yawan dogara ga kantin magani da kantin magani yana shafar kasuwa a kaikaice. A cewar rahoton lafiya da tsufa na duniya, ana hasashen adadin mutanen da suka haura shekaru 65 ko sama da haka zai karu daga kimanin miliyan 524 a shekarar 2010 zuwa kusan biliyan 1.5 a shekarar 2050, inda akasarin karuwar a kasashe masu tasowa. Akwai wasu yanayi na kiwon lafiya da ake tsammanin za su zama ƙalubale ga tsarin kula da lafiyar mu tare da karuwar yawan tsufa. Waɗannan sharuɗɗan sun haɗa da ciwon daji, ciwon hauka, da karuwar yawan faɗuwa, kiba, da ciwon sukari. Binciken kasuwannin kantin magani ya nuna cewa saboda karuwar yawan tsufa, ana sa ran adadin masu kamuwa da cutar zai karu, don haka samar da tushen karuwar abokan ciniki ga kantin magani da shagunan magunguna.
A duniya kantin magani da kantin sayar da magunguna ana tsammanin yayi girma daga dala biliyan 971.51 a cikin 2020 zuwa dala biliyan 1038.6 a cikin 2021 a ƙimar haɓakar shekara-shekara (CAGR) na 6.9%. Canjin yanayin ci gaban ya fi yawa saboda kamfanonin da ke daidaita kayan aikin su bayan sun biya bukatun da suka girma sosai yayin bala'in COVID-19 a cikin 2020. Ana sa ran girman kasuwar kantin magani ya kai dala biliyan 1299.8 a cikin 2025 a CAGR na 6%.
Ga Jerin Kwatankwacin Rahotannin Daga Kamfanin Binciken Kasuwancin:
Rahoton Kasuwar Duniya na 2021: Pharmacy da Stores Stores kiwon lafiya: Tasirin COVID-19 da farfadowa zuwa 2030
https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report-2020-30-covid-19-impact-and-recovery
Kasuwar Magunguna - Ta Nau'in (Magungunan Magunguna, Ilimin Halittu), Ta Nau'in Magungunan Magunguna (Magungunan Magungunan Zuciya, Magungunan cututtukan fata, Magungunan Gastrointestinal, Magungunan Jiki-Urinary, Magungunan Hematology, Magungunan Magungunan Magunguna, Magungunan Magungunan Magunguna, Cutar Kwayar cuta ta Tsakiya, Cututtukan ƙwayar cuta ta tsakiya, Ciwon ƙwayar cuta na ƙwayar cuta ta tsakiya Magungunan Tsarin Tsarin, Magungunan Oncology, Magungunan Ophthalmology, Magungunan Cututtuka na Numfashi), Ta Nau'in Magungunan Halittu (Antibodies Monoclonal (MAbs), Sunadaran Magunguna, Alurar rigakafi), Kuma Ta Yanki, Dama da Dabaru - Hasashen Duniya Zuwa 2030
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Kasuwar Magungunan Dabbobi - Ta Nau'in Dabbobi (Kiwon Dabbo, Dabbobin Dabbobi), Ta Nau'in Magungunan Magunguna (Magungunan Dabbobi, Magungunan Dabbobi, Magungunan Magungunan Dabbobi, Wasu), Ta Hanyar Gudanarwa (Na baka, Wasu), Ta Hanyar Amfani, Da Ta Yanki, Dama da Dama Dabaru - Hasashen Duniya Zuwa 2030
https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-market
Ana sha'awar sanin game da Kamfanin Binciken Kasuwanci?
Kamfanin Binciken Kasuwanci kamfani ne na leken asirin kasuwa wanda yayi fice a cikin kamfani, kasuwa, da kuma binciken masu amfani. Kasancewa a duniya yana da ƙwararrun mashawarta a yawancin masana'antu ciki har da masana'antu, kiwon lafiya, sabis ɗin kuɗi, sunadarai, da fasaha.
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- Yawan geriatric ya fi saurin kamuwa da kamuwa da cututtuka da yawa waɗanda ke haɓaka dogaro ga kantin magani da shagunan magunguna da ke shafar kasuwa a kaikaice.
- A cewar rahoton Kiwon Lafiya da tsufa na Duniya, an yi hasashen adadin mutanen da suka kai shekaru 65 ko sama da haka zai karu daga kimanin miliyan 524 a shekarar 2010 zuwa kusan 1.
- Binciken kasuwannin kantin magani ya nuna cewa saboda karuwar yawan tsufa, ana sa ran adadin masu kamuwa da cutar zai karu, don haka samar da tushen karuwar abokan ciniki ga kantin magani da shagunan magunguna.
